Meet be.well™, our simple, easy-to-use solution that puts molecular diagnostics and test results in the palm of your hand.
Alveo’s be.well™ system and companion mobile app are designed for point-of-care use and deliver rapid, accurate results to determine the presence or absence of disease.
According to the World Health Organization, seasonal influenza epidemics result in three to five million cases of severe illness every year1.
Since the onset of the COVID-19 pandemic in 2019, global impact of respiratory illness continues to grow. Timely diagnosis is critical to healthcare providers to ensure appropriate, timely and effective care. Our be.well system uses molecular LAMP technology to enable rapid testing and action for the treatment and prevention of illness.